FTC Testifies on Barriers to the Entry of Generic Drugs
Date
Testifying today on behalf of the Federal Trade Commission before the U.S. Senate’s Special Committee on Aging, Commissioner Jon Leibowitz described the FTC’s work in the area of branded and generic...